Liveware
Subscribe
Sign in
Home
Notes
Archive
About
Actions per minute
What StarCraft 2 taught me about B2B SaaS
May 23, 2025
•
Alex Telford
7
Some notes on the aesthetic of progress
Progress art as harmony between technology and nature
Mar 17, 2024
•
Alex Telford
27
8
5
But does surgery really work well without the FDA?
Or maybe the FDA is good actually
Feb 10, 2024
•
Alex Telford
13
13
2
The burden of prestige
Reflections on “The Trajectory of Discovery”, by Mark Khurana
Dec 19, 2023
•
Alex Telford
12
3
1
Depression as a local minima
Do antidepressants work via simulated annealing?
Dec 6, 2023
•
Alex Telford
7
3
1
Latent optima
In which I argue that information about optimality is encoded into datasets by selection processes
Nov 17, 2023
•
Alex Telford
2
Super Mario, scientist
What video game speedrunning can teach us about automating scientific discovery
Nov 7, 2023
•
Alex Telford
14
3
Schadenfreude in drug development
Optimism as a moral duty
Oct 26, 2023
•
Alex Telford
6
Should the UK embrace its role as an exporter of talent and ideas?
A proposal for a UK 'sovereign innovation fund'
Oct 19, 2023
•
Alex Telford
3
2
Concepts of health and disease as a barrier to progress
This essay was the runner-up in the Homeworld Ideas writing contest.
Oct 16, 2023
•
Alex Telford
8
1
Liveware
I write about the science and business of living things: the biotech industry, drug discovery, biology, medicine, consciousness, intelligence (artificial and natural), and natural philosophy. Mostly I write about the biotech industry.
Subscribe
Recommendations
Asymmetric Learning - Pharmaceutical Innovation
Mike Rea, SAI/ IDEA Pharma
The Roots of Progress
Jason Crawford
Asimov Press
Asimov Press
Liveware
Subscribe
About
Archive
Recommendations
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts